Thursday, April 10, 2025
Session | Time | Room | Title | Organizers |
---|---|---|---|---|
S1A | 10:15-11:45am | Trinity A/B | Honoring Dr. Richard Simon | Marlina Nasution, PhD (AskBio) Shuyen Ho, PhD (Consultant) |
S1B | 10:15-11:45am | Trinity C | Covariate Adjustment in Clinical Trials | Rakhi Kilaru, MS, MBA (PPD clinical research business of Thermo Fisher Scientific) Yeh-Fong Chen, PhD (FDA) |
S1C | 10:15-11:45am | Trinity D | Statistical Methods in Restricted Mean Survival Time | Hwanhee Hong, PhD (Duke) Kaiyuan Hua, PhD (Duke) |
S1D | 10:15-11:45am | Trustees 1/2 | Recent Advances in Computing, Optimization, and Causal Inference for Adaptive Clinical Trials | Brad Carlin, PhD (PhaseV Trials) |
S2A | 1:30-3:00pm | Trinity A/B | Innovative Statistical Methods in Biomarker-Assisted Drug Development | Shibing Deng, PhD (Pfizer) |
S2B | 1:30-3:00pm | Trinity C | Quantitative Leadership and Innovation to Accelerate Drug Development: Insights from Leaders in Statistics & Data Science | Charlotte Baidoo, MMath (Bristol Myers Squibb) Mariann Micsinai-Balan, PhD (Bristol Myers Squibb) |
S2C | 1:30-3:00pm | Trinity D | Advances in Use of External and Literature Data for Clinical Development and Surveillance: Bayesian, AI/ML and More | Jian Zhu, PhD (Servier) Cindy Gao, PhD (FDA) |
S2D | 1:30-3:00pm | Trustees 1/2 | Pediatric Drug Development: Emerging Innovations and Future Directions | Jingjing Ye, PhD (BeiGene) Freda Cooner (FDA) |
S3A | 3:15-5:00pm | Trinity A/B | Journey to Dose Optimization in Oncology- Challenges and Learning through Designs and Applications | James Rogers, PhD (Metrum Research Group) Nicole Li, PhD (BeiGene) |
S3B | 3:15-5:00pm | Trinity C | Poster Lightening Talks | Roland Matsouaka, PhD (Duke) Lisa Wruck, PhD (Duke) |
S3C | 3:15-5:00pm | Trinity D | Recent Advances in Statistical Methodology for Biosimilar and Bioequivalence Studies | Fairouz Makhlouf, PhD (FDA) |
S3D | 3:15-5:00pm | Trustees 1/2 | Challenges and Opportunities of ML/AL in Drug Development | Zhaoyang Teng, PhD (Servier) Wenqiong Xue, PhD (Boehringer Ingelheim) |